North America Primary Angle-Closure Glaucoma Market – Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Published Report
  • Aug 2021
  • North America
  • 350 Pages
  • No of Tables: 35
  • No of Figures: 36

North America Primary Angle-Closure Glaucoma Market, By Disease Type (Acute Angle-Closure Glaucoma and Chronic Angle-Closure Glaucoma), Type (Diagnosis and Treatment), End User (Hospitals, Ambulatory Surgical Centres, Specialty Clinics and Others), Distribution Channel (Direct Tender, Retail Sales and Others), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2028.

North America Primary Angle-Closure Glaucoma Market,  By DevelopmentsMarket Analysis and Insights: North America Primary Angle-Closure Glaucoma Market

North America primary angle-closure glaucoma market is expected to gain significant growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.7% in the forecast period of 2021 to 2028 and is expected to reach USD 176.34 million by 2028 from USD 113.24 million in 2020. Rising prevalence of angle-closure glaucoma and rise in geriatric population are major drivers which are expected to propel growth of the market in the forecast period.

Glaucoma is a group of eye conditions that damage the optic nerve, and the proper functioning of the optic nerve is necessary for good vision. This damage is often caused by abnormally high pressure in the eye. The primary angle closure (PAC) is defined as appositional closure of the anterior chamber angle which can lead to aqueous outflow obstruction and raised IOP, in the absence of glaucomatous optic neuropathy. PAC is generally bilateral; a primary angle-closure glaucoma market includes the technique of detection of primary angle-closure glaucoma in early-stage to conduct the future surgical treatment approach which can decrease the blindness rate associated with primary angle closure. The asymptomatic nature of the disease in the early stage causes improper or inaccurate diagnosis of primary angle-closure glaucoma leads to wrong treatment which causes an extra burden on the patient’s pocket and causes a decrease in reliability for the diagnostics product.

Rising prevalence of angle-closure glaucoma and rise in geriatric population are boosting growth of the North America primary angle-closure glaucoma market. However, high surgical cost of PACG and inadequate reimbursement scenario are expected to hamper the market growth in the forecasted period. On the other hand, recent approval of governing bodies and increase of government initiatives towards glaucoma are anticipated to impel the market growth. Lack of skilled professionals and limited access to treatment may act as a challenge for the market growth,

The North America primary angle-closure glaucoma market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.   

North America Primary Angle-Closure Glaucoma Market,  By DevelopmentsNorth America Primary Angle-Closure Glaucoma Market Scope and Market Size

The North America primary angle-closure glaucoma market is segmented on the basis of disease type, type, end user, and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of disease type, the primary angle-closure glaucoma market is segmented into acute angle-closure glaucoma and chronic angle-closure glaucoma. In 2021, acute angle-closure glaucoma segment is expected to dominate in the primary angle-closure glaucoma market owing to the high incidence cases for acute cases. Acute attack of angle closure glaucoma is at high risk and the maximum number of cases which ophthalmologist diagnose are of acute angle closure glaucoma.
  • On the basis of type, the primary angle-closure glaucoma market is segmented into diagnosis and treatment. In 2021, diagnosis segment is expected to dominate in the primary angle-closure glaucoma market due to the primary test and secondary testing options available for the diagnosis and physicians after a proper diagnosis only prefer the medical procedure. Treatment segment in this market is totally based on surgical intervention due to which the market share for treatment is less than diagnosis.
  • On the basis of end user, the primary angle-closure glaucoma market is segmented into hospitals, specialty clinics, ambulatory surgical centres, and others. In 2021, hospital segment is expected to dominate the primary angle-closure glaucoma market this segment is specialized in conducting various surgical interventions and have a large professional’s portfolio available for giving the proper treatment. Moreover, cost-effective and high quality diagnostic care and services in safe healthcare environment and are convenient for consulting physician/healthcare institution to outsource bulk diagnostics tests to independent diagnostic laboratories for better customer services.
  • On the basis of distribution channel, the primary angle-closure glaucoma market is segmented into direct tender, retail sales and others. In 2021, direct tender segment is expected to dominate the primary angle-closure glaucoma market as they are the primary source of procurement of diagnostic and surgical devices by healthcare organizations and specialty clinics. With the increasing cost of healthcare, healthcare service providers are focusing on better services for customers along with reducing the overall cost. The procurement of products through direct tender is highly cost effective for healthcare providers.

North America Primary Angle-Closure Glaucoma Market,  By DevelopmentsNorth America Primary Angle-Closure Glaucoma Market Country Level Analysis

The North America primary angle-closure glaucoma market is analysed and market size information is provided product, disease type, type, end user, and distribution channel.

The countries covered in the North America primary angle-closure glaucoma market report are U.S., Canada, and Mexico.

  • In 2021, U.S. is expected to dominate the market due to the presence of the largest consumer market with high GDP. Moreover, the U.S. has the largest research and development spending in the world and offers trade agreements with several countries making it the largest market for consumer primary angle closure glaucoma diagnosis and surgical products. Canada is expected to showcase substantial growth in the North America market due to increasing economic burden of the country. On the other hand, Mexico is expected to grow in the forecast period of 2021 to 2028 due to rising geriatric population in the country.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

Rising Geriatric Population and Growing Prevalence of Angle-Closure Glaucoma in the Region are Creating New Opportunities for Players in the North America Primary Angle-Closure Glaucoma Market

North America primary angle-closure glaucoma market also provides you with detailed market analysis for every country growth in particular industry with the primary angle-closure glaucoma market sales, impact of advancement in the primary angle-closure glaucoma market and changes in regulatory scenarios with their support for the primary angle-closure glaucoma market. The data is available for historic period 2010 to 2019.

Competitive Landscape and North America Primary Angle-Closure Glaucoma Market Share Analysis

North America primary angle-closure glaucoma market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, and technology lifeline curve. The above data points provided are only related to the company’s focus related to primary angle-closure glaucoma market.

The major companies covered in the report are Johnson & Johnson Vision Care, Inc. (A Subsidiary of Johnson & Johnson Services Inc.), New World Medical, Inc., Sight Sciences, Inc., NIDEK CO., LTD, BVI, MicroSurgical Technology, Allergan (A Subsidiary of AbbVie Inc.), Bausch & Lomb Incorporated (A Subsidiary of Bausch Health Companies Inc.), Oertli Instrumente AG, NOVAEYE MEDICAL, ZEISS International, Alcon Inc., LIGHTMED, Luneau Technology USA, Reichert, Inc. (A Business Unit of Ametek Inc.), and NEW VISION among others.

Several product launches and agreements are also initiated by the companies’ worldwide, which are also accelerating the primary angle-closure glaucoma market.

For instance,

  • In October 2019, MicroSurgical Technology announced that they have acquired the Trabectome and Goniotome surgical system from Neomedix Corporation. Trabectome is used in major surgical technology for glaucoma. This acquisition increased the product portfolio for the company and hence enhanced the profit for the company
  • In October 2018, Reichert, Inc. announced the introduction of their new Tono-Pen AVIA Handheld Tonometer now with Quick-Tap measurement mode. Quick-Tap is ideal for patients who are sensitive to applanation tonometry or for post-operative patients. This was easy to use instrument owing to the rise in demand among patients

Customization Available: North America Primary Angle-Closure Glaucoma Market  

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES 

TABLE 1 NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, PIPELINE ANALYSIS

TABLE 2 NUMBER OF OPHTHALMOLOGISTS/MILLION POPULATIONS

TABLE 3 NORTH AMERICA PRIMARY ANGLE CLOSURE GLAUCOMA MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 4 NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY TYPE 2019-2028 (USD MILLION)

TABLE 5 NORTH AMERICA DIAGNOSIS IN PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY TYPE 2019-2028 (USD MILLION)

TABLE 6 NORTH AMERICA PRIMARY TEST IN PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY TYPE 2019-2028 (USD MILLION)

TABLE 7 NORTH AMERICA SECONDARY TEST IN PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY TYPE 2019-2028 (USD MILLION)

TABLE 8 NORTH AMERICA TREATMENT IN PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY TYPE 2019-2028 (USD MILLION)

TABLE 9 NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 10 NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 11 NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 12 U.S. PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET , BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 13 U.S. PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY TYPE 2019-2028 (USD MILLION)

TABLE 14 U.S. DIAGNOSIS IN PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY TYPE 2019-2028 (USD MILLION)

TABLE 15 U.S. PRIMARY TEST IN PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY TYPE 2019-2028 (USD MILLION)

TABLE 16 U.S. SECONDARY TEST IN PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY TYPE 2019-2028 (USD MILLION)

TABLE 17 U.S. TREATMENT IN PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY TYPE 2019-2028 (USD MILLION)

TABLE 18 U.S. PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 19 U.S. PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 20 CANADA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET , BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 21 CANADA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY TYPE 2019-2028 (USD MILLION)

TABLE 22 CANADA DIAGNOSIS IN PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY TYPE 2019-2028 (USD MILLION)

TABLE 23 CANADA PRIMARY TEST IN PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY TYPE 2019-2028 (USD MILLION)

TABLE 24 CANADA SECONDARY TEST IN PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY TYPE 2019-2028 (USD MILLION)

TABLE 25 CANADA TREATMENT IN PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY TYPE 2019-2028 (USD MILLION)

TABLE 26 CANADA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 27 CANADA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 28 MEXICO PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET , BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 29 MEXICO PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY TYPE 2019-2028 (USD MILLION)

TABLE 30 MEXICO DIAGNOSIS IN PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY TYPE 2019-2028 (USD MILLION)

TABLE 31 MEXICO PRIMARY TEST IN PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY TYPE 2019-2028 (USD MILLION)

TABLE 32 MEXICO SECONDARY TEST IN PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY TYPE 2019-2028 (USD MILLION)

TABLE 33 MEXICO TREATMENT IN PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY TYPE 2019-2028 (USD MILLION)

TABLE 34 MEXICO PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 35 MEXICO PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

 

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions